by pulsepartner | Apr 8, 2026 | Blog Post
A recent report from the Information Technology and Innovation Foundation (ITIF), “Antitrust Undone: How Competition Enforcers Are Undermining Competition,” highlights the risks of unnecessarily aggressive antitrust enforcement in innovative industries. The report...
by pulsepartner | Mar 5, 2026 | Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by pulsepartner | Feb 18, 2026 | Blog Post
Life sciences mergers and acquisitions (M&A) activity gained momentum in late 2025, and that acceleration is expected to continue in 2026. This positive trend is vitally important for the many treatments and cures that depend on these partnerships to reach...
by pulsepartner | Feb 5, 2026 | Blog Post
New research presented at a Congressional staff briefing highlighted the strong, positive relationship between pharmaceutical mergers and acquisitions (M&A) and the launches of new drugs for patients. Research Finds that Pharmaceutical M&A Drives New, Novel...
by pulsepartner | Dec 19, 2025 | Blog Post
This year, life sciences mergers and acquisitions (M&A) played a crucial role in driving innovation and supporting America’s global leadership in the life sciences. As the leading advocacy coalition on life sciences M&A, PULSE educated stakeholders and...
by pulsepartner | Dec 10, 2025 | Blog Post
Following a challenging funding and policy environment, new data shows an uptick in biopharmaceutical mergers and acquisitions (M&A). This is an encouraging sign of a healthy biopharmaceutical innovation ecosystem. As experts observe continued funding pressures on...
